IL75927A0 - Retroviral vaccines and vectors and methods for their construction - Google Patents
Retroviral vaccines and vectors and methods for their constructionInfo
- Publication number
- IL75927A0 IL75927A0 IL75927A IL7592785A IL75927A0 IL 75927 A0 IL75927 A0 IL 75927A0 IL 75927 A IL75927 A IL 75927A IL 7592785 A IL7592785 A IL 7592785A IL 75927 A0 IL75927 A0 IL 75927A0
- Authority
- IL
- Israel
- Prior art keywords
- vectors
- construction
- methods
- retroviral
- vaccines
- Prior art date
Links
- 238000010276 construction Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000001177 retroviral effect Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63272384A | 1984-07-20 | 1984-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL75927A0 true IL75927A0 (en) | 1985-12-31 |
Family
ID=24536672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL75927A IL75927A0 (en) | 1984-07-20 | 1985-07-26 | Retroviral vaccines and vectors and methods for their construction |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0188574A1 (en) |
IL (1) | IL75927A0 (en) |
WO (1) | WO1986000930A1 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925784A (en) * | 1986-04-04 | 1990-05-15 | Hoffmann-La Roche Inc. | Expression and purification of an HTLV-III gag/env gene protein |
US5997859A (en) * | 1988-03-21 | 1999-12-07 | Chiron Corporation | Method for treating a metastatic carcinoma using a conditionally lethal gene |
US5716826A (en) * | 1988-03-21 | 1998-02-10 | Chiron Viagene, Inc. | Recombinant retroviruses |
US6569679B1 (en) | 1988-03-21 | 2003-05-27 | Chiron Corporation | Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene |
US6133029A (en) * | 1988-03-21 | 2000-10-17 | Chiron Corporation | Replication defective viral vectors for infecting human cells |
US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US6867195B1 (en) | 1989-03-21 | 2005-03-15 | Vical Incorporated | Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected |
US6214804B1 (en) | 1989-03-21 | 2001-04-10 | Vical Incorporated | Induction of a protective immune response in a mammal by injecting a DNA sequence |
US5693622A (en) * | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
DE69034078T2 (en) † | 1989-03-21 | 2004-04-01 | Vical, Inc., San Diego | Expression of exogenous polynucleotide sequences in vertebrates |
US6673776B1 (en) | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
US5665587A (en) * | 1989-06-26 | 1997-09-09 | Novo Nordisk A/S | Modified subtilisins and detergent compositions containing same |
WO1991006658A2 (en) * | 1989-10-24 | 1991-05-16 | Cetus Corporation | Infective protein delivery system |
ES2113371T3 (en) | 1989-11-16 | 1998-05-01 | Univ Duke | TRANSFORMATION OF EPIDERMIC CELLS FROM ANIMAL TISSUES WITH THE HELP OF PARTICLES. |
US6706694B1 (en) | 1990-03-21 | 2004-03-16 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate |
US6228844B1 (en) | 1991-11-12 | 2001-05-08 | Vical Incorporated | Stimulating vascular growth by administration of DNA sequences encoding VEGF |
US5643578A (en) | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
US5620896A (en) * | 1992-03-23 | 1997-04-15 | University Of Massachusetts Medical Center | DNA vaccines against rotavirus infections |
US6165993A (en) * | 1992-03-23 | 2000-12-26 | University Of Massachusetts Medical Center | DNA vaccines against rotavirus infections |
WO1995014091A2 (en) | 1993-11-18 | 1995-05-26 | Chiron Viagene, Inc. | Compositions and methods for utilizing conditionally lethal genes |
US6995008B1 (en) | 1994-03-07 | 2006-02-07 | Merck & Co., Inc. | Coordinate in vivo gene expression |
US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
US5888814A (en) * | 1994-06-06 | 1999-03-30 | Chiron Corporation | Recombinant host cells encoding TNF proteins |
US5837533A (en) * | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
US5962428A (en) * | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
RU2621146C1 (en) * | 2016-09-23 | 2017-05-31 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский ветеринарный институт Нечернозёмной зоны Российской Федерации" (ФГБНУ "НИВИ НЗ России") | Prevention method of postnatal infection by bovine leukosis virus of the young bovine stock |
-
1985
- 1985-07-18 WO PCT/US1985/001352 patent/WO1986000930A1/en unknown
- 1985-07-18 EP EP85903758A patent/EP0188574A1/en not_active Withdrawn
- 1985-07-26 IL IL75927A patent/IL75927A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1986000930A1 (en) | 1986-02-13 |
EP0188574A1 (en) | 1986-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL75927A0 (en) | Retroviral vaccines and vectors and methods for their construction | |
IL75223A0 (en) | Arylhydroxamates and processes for the preparation thereof | |
GB8608897D0 (en) | Polypeptide | |
ZA857124B (en) | 13-halomilbemycins and 13-hydroxymilbemycins | |
GB2168065B (en) | Polyanhydride-siloxanes and polyimide-siloxanes obtained therefrom | |
GB8502552D0 (en) | Retaining means | |
DE3569726D1 (en) | Polymerizable 3-aroyloxyphenyl carbamates and methods for their preparation and use | |
GB8610243D0 (en) | Antigens | |
DE3367915D1 (en) | Preparing 7-alkoxybenzofurans and intermediates used therein | |
DE3367386D1 (en) | Preparing 4,7-dialkoxybenzofurans, and intermediates used therein | |
ZA858034B (en) | Antigens | |
GB8531508D0 (en) | Vaccine | |
ZA858789B (en) | Vaccines | |
DE3570274D1 (en) | Dewar apparatus | |
NZ214660A (en) | Ovine foot-rot vaccine | |
ZA859297B (en) | Process and vaccine | |
GB8619804D0 (en) | Vaccine | |
GB8529759D0 (en) | Polypeptide | |
GB8715737D0 (en) | Polypeptide | |
GB8723507D0 (en) | Polypeptide | |
IL75224A (en) | Tetrahydronaphthalenols and processes for the preparation thereof | |
CS227484A1 (en) | Zpusob vyroby tlumiciho plaste | |
GB8529127D0 (en) | Expression vectors | |
GB8426366D0 (en) | Vaccines | |
GB8429392D0 (en) | Vectors |